TABLE 3.
Clinical characteristics | ARVC | Brugada | P value |
---|---|---|---|
Age at enrolment (years) | 55.0 ± 7.3 | 52.6 ± 14.7 | .73 |
ECG | |||
PQ interval (ms) | 210 (170‐278) | 180 (163‐208) | .13 |
QRS duration (ms) | 138 ± 25 | 118 ± 31 | .18 |
Complete right bundle brunch block, n (%) | 3 (60) | 8 (31) | .22 |
Fragmented QRS, n (%) | 3 (60) | 8 (31) | .22 |
T‐wave inversion in leads V1‐V3, n (%) | 3 (60) | 16 (62) | .95 |
T‐wave inversion in leads II/III/aVF, n (%) | 1 (20) | 3 (12) | .62 |
J wave in inferior/lateral lead, n (%) | 1 (20) | 4 (15) | .80 |
Positive in SAECG, n (%) | 4/4 (100) | 8/13 (62) | .07 |
J‐point amplitude of Brugada pattern (mV) | 0.29 ± 0.05 | 0.66 ± 0.33 | <.001 |
S‐wave amplitude of Brugada pattern (mV) | 0.34 ± 0.21 | 0.67 ± 0.39 | .017 |
Episode of VF, n (%) | 0 (0) | 26 (100) | <.001 |
Episode of monomorphic VT, n (%) | 4 (80) | 0 (0) | <.001 |
Values are presented as mean ± SD, median (interquartile range), or n (%).
VF, ventricular fibrillation; VT, ventricular tachycardia.